AURKA participates in the control of NF-κB and Wnt/β-catenin pathways, associated with the resistance and progression of MM (Dutta-Simmons et al., 2009; Mazzera et al., 2013; Zhou et al., 2013; Huynh et al., 2018). This evidence concerns the gene AURKA and Miyoshi myopathy.